These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10718119)

  • 1. Fenamates and the potent inhibition of human liver phenol sulphotransferase.
    Vietri M; De Santi C; Pietrabissa A; Mosca F; Pacifici GM
    Xenobiotica; 2000 Feb; 30(2):111-6. PubMed ID: 10718119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human liver phenol sulfotransferase by nonsteroidal anti-inflammatory drugs.
    Vietri M; De Santi C; Pietrabissa A; Mosca F; Pacifici GM
    Eur J Clin Pharmacol; 2000 Apr; 56(1):81-7. PubMed ID: 10853883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates.
    Kankaanranta H; Moilanen E; Vapaatalo H
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Dec; 350(6):685-91. PubMed ID: 7708126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of two human sulphotransferase cDNAs that encode monoamine- and phenol-sulphating forms of phenol sulphotransferase: substrate kinetics, thermal-stability and inhibitor-sensitivity studies.
    Veronese ME; Burgess W; Zhu X; McManus ME
    Biochem J; 1994 Sep; 302 ( Pt 2)(Pt 2):497-502. PubMed ID: 8093002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human adult and foetal liver sulphotransferases: inhibition by mefenamic acid and salicylic acid.
    Vietri M; Pietrabissa A; Mosca F; Rane A; Pacific GM
    Xenobiotica; 2001 Mar; 31(3):153-61. PubMed ID: 11465392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.
    Gaganis P; Miners JO; Knights KM
    Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of glutamate and glycine transporters by niflumic, flufenamic and mefenamic acids.
    Habjan S; Vandenberg RJ
    Neurochem Res; 2009 Oct; 34(10):1738-47. PubMed ID: 19444608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of fenamates on Ca-activated chloride and potassium currents in rabbit portal vein smooth muscle cells.
    Greenwood IA; Large WA
    Br J Pharmacol; 1995 Dec; 116(7):2939-48. PubMed ID: 8680728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenamates may antagonize the actions of prostaglandin endoperoxides in human myometrium.
    Sanger GJ; Bennett A
    Br J Clin Pharmacol; 1979 Nov; 8(5):479-82. PubMed ID: 508555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flufenamic acid, mefenamic acid and niflumic acid inhibit single nonselective cation channels in the rat exocrine pancreas.
    Gögelein H; Dahlem D; Englert HC; Lang HJ
    FEBS Lett; 1990 Jul; 268(1):79-82. PubMed ID: 1696554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The action of flufenamic acid and other nonsteroidal anti-inflammatories on sulfate transport in the isolated perfused rat liver.
    Lopez CH; Bracht A; Yamamoto NS; Ishii-Iwamoto EL; Sampaio E; Kelmer-Bracht AM
    Gen Pharmacol; 1999 Jun; 32(6):713-20. PubMed ID: 10401997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by fenamates of calcium influx and proliferation of human lymphocytes.
    Kankaanranta H; Luomala M; Kosonen O; Moilanen E
    Br J Pharmacol; 1996 Oct; 119(3):487-94. PubMed ID: 8894168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid hormone uptake by hepatocytes: structure-activity relationships of phenylanthranilic acids with inhibitory activity.
    Chalmers DK; Scholz GH; Topliss DJ; Kolliniatis E; Munro SL; Craik DJ; Iskander MN; Stockigt JR
    J Med Chem; 1993 Apr; 36(9):1272-7. PubMed ID: 8487264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental observations on flufenamic, mefenamic, and meclofenamic acids. I. Pharmacology.
    Winder CV
    Ann Phys Med; 1966; Suppl():7-16. PubMed ID: 6004862
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of the fenamates on the threshold of pain.
    Haward LR
    Ann Phys Med; 1966; Suppl():55-7. PubMed ID: 4895007
    [No Abstract]   [Full Text] [Related]  

  • 16. Raman and IR spectroscopic studies of fenamates--conformational differences in polymorphs of flufenamic acid, mefenamic acid and tolfenamic acid.
    Jabeen S; Dines TJ; Leharne SA; Chowdhry BZ
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Oct; 96():972-85. PubMed ID: 22954807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hKv2.1, a major human neuronal voltage-gated K+ channel, by meclofenamic acid.
    Lee YT; Wang Q
    Eur J Pharmacol; 1999 Aug; 378(3):349-56. PubMed ID: 10493112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral antipyretic therapy: evaluation of the N-aryl-anthranilic acid derivatives mefenamic acid, tolfenamic acid and flufenamic acid.
    Keinänen S; Similä S; Kouvalainen K
    Eur J Clin Pharmacol; 1978 Jul; 13(5):331-44. PubMed ID: 668793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of mefenamic acid and flufenamic acid on plasma uric acid levels.
    Latham BA; Radcliff F; Robinson RG
    Ann Phys Med; 1966 Aug; 8(7):242-3. PubMed ID: 5918265
    [No Abstract]   [Full Text] [Related]  

  • 20. Fenamates inhibit human sodium channel Nav1.7 and Nav1.8.
    Sun JF; Xu YJ; Kong XH; Su Y; Wang ZY
    Neurosci Lett; 2019 Mar; 696():67-73. PubMed ID: 30528877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.